Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BicHD: Oral Sodium Bicarbonate in Haemodialysis Patients
NCT02692378Phase 4Completed
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Nov 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium bicarbonate in metabolic acidosis and hyperkalemia, sponsored by Imperial College Healthcare NHS Trust. Primary endpoints: Pre-dialysis potassium level and Intradialytic potassium gradient. Started Nov 2015; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
metabolic acidosishyperkalemia
Beyond the preview
Go deeper on NCT02692378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02692378.